Amedisys Stock Widgets and Gadgets
AMED Stock | USD 90.40 0.38 0.42% |
Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- AMED Amedisys
- Latest New York State Teachers Retirement System Lowers Stock Position in Amedisys, Inc. - Defense World
- AMED 90.4 -0.38
- Low 90.34
- High 90.98
- Volume 384.9 K
- Alpha -0.0909
- Beta 0.19
- Return On Equity -0.0098
- Return On Asset 0.0598
- Profit Margin (0) %
- Operating Margin 0.08 %
- Current Valuation 3.38 B
- Shares Outstanding 32.67 M
- Shares Owned By Insiders 2.26 %
- Shares Owned By Institutions 96.17 %
- Number Of Shares Shorted 2.49 M
- Price To Earning 15.03 X
- Price To Book 2.81 X
- Price To Sales 1.34 X
- Revenue 2.24 B
- Gross Profit 453.98 M
- EBITDA 216.91 M
- Net Income (9.75 M)
- Cash And Equivalents 17.96 M
- Cash Per Share 0.55 X
- Total Debt 487.21 M
- Debt To Equity 0.53 %
- Current Ratio 1.06 X
- Book Value Per Share 32.65 X
- Cash Flow From Operations 137.19 M
- Short Ratio 7.11 X
- Earnings Per Share (0.30) X
- Price To Earnings To Growth 1.35 X
- Target Price 97.78
- Number Of Employees 19 K
- Beta 0.86
- Market Capitalization 2.97 B
- Total Asset 2.06 B
- Retained Earnings 747.92 M
- Working Capital 23.21 M
- Current Asset 175.26 M
- Current Liabilities 175.19 M
- Net Asset 2.06 B
- Accumulation Distribution 2707.61
- Daily Balance Of Power (0.59)
- Rate Of Daily Change 1.0
- Day Median Price 90.66
- Day Typical Price 90.57
- Price Action Indicator (0.45)
- Period Momentum Indicator (0.38)
Market Snapshot Widget Example
DAX Index Germany | 17,737 0.56 | |
Taiwan Weighted Taiwan | 19,527 3.81 | |
PSI 20 Stock Portugal | 6,295 0.51 | |
CROBEX Croatia | 2,799 0.14 | |
Budapest SE Hungary | 65,045 0.96 | |
IDX 30 Jakarta Indonesia | 466.84 1.6 | |
ISEQ 20 Price Ireland | 1,646 1.15 | |
NYSE Comp USA | 17,459 0.41 | |
Tel Aviv 35 Israel | 1,912 1.29 | |
Coreshares Index Tracker South Afric | 1,020 0.97 | |
IPC MEXICO Mexico | 55,863 0.09 | |
KL Technology Malaysia | 62.78 1.74 | |
IBEX 35 Index Spain | 10,730 0.33 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,537 0.04 | |
SPASX Dividend Opportunities Australia | 1,644 1.01 | |
HNX 30 Vietnam | 467.39 3.61 | |
Bucharest BET-NG Romania | 1,206 0.08 | |
AMS Small Cap Netherlands | 1,190 1.5 | |
Oslo Exchange Mutual Norway | 1,290 0.08 | |
BEL Small Belgium | 8,954 0.09 | |
RTSI Index Russia | 1,174 1.18 | |
Basic Materials Brazil | 5,969 1.73 | |
Swiss Leader Price Switzerland | 1,840 0.16 | |
Fondo Mutuo ETF Chile | 1,410 1.27 | |
Athens General Comp Greece | 1,393 0.84 | |
Stock Exchange Of Thailand | 1,332 2.13 | |
PX Prague Stock Czech Repub | 1,550 0.18 | |
THE PHILIPPINE STOCK Philippines | 6,443 1.23 | |
WIG 30 Poland | 3,049 0.06 | |
BIST Electricity Turkey | 592.17 1.43 |
Investing Ideas
In addition to having Amedisys in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Amedisys
Compare Amedisys To Peers
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amedisys. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.Note that the Amedisys information on this page should be used as a complementary analysis to other Amedisys' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for Amedisys Stock analysis
When running Amedisys' price analysis, check to measure Amedisys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amedisys is operating at the current time. Most of Amedisys' value examination focuses on studying past and present price action to predict the probability of Amedisys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amedisys' price. Additionally, you may evaluate how the addition of Amedisys to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |
Is Amedisys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amedisys. If investors know Amedisys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amedisys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.40) | Earnings Share (0.30) | Revenue Per Share 68.603 | Quarterly Revenue Growth 0.016 | Return On Assets 0.0598 |
The market value of Amedisys is measured differently than its book value, which is the value of Amedisys that is recorded on the company's balance sheet. Investors also form their own opinion of Amedisys' value that differs from its market value or its book value, called intrinsic value, which is Amedisys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amedisys' market value can be influenced by many factors that don't directly affect Amedisys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amedisys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amedisys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amedisys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.